43
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Formation of Stable Epoxides in the Metabolism of Tricyclic Drugs

, &
Pages 197-218 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

C. S. Lee, L. H. Wang, T. C. Marbury, J. Bruni & R. J. Perchalski. (1980) Hemodialysis Clearance and Total Body Elimination of Carbamazepine during Chronic Hemodialysis. Clinical Toxicology 17:3, pages 429-438.
Read now
K.-J. Hoffmann, A. Arfwidsson, K. O. Borg & I. Skånberg. (1979) Identification of Urinary and Biliary Metabolites of Alprenolol in the Rat. Xenobiotica 9:2, pages 93-106.
Read now
Bernard Testa & Peter Jenner. (1978) Novel Drug Metabolites Produced by Functionalization Reactions: Chemistry and Toxicology. Drug Metabolism Reviews 7:2, pages 325-369.
Read now

Articles from other publishers (18)

René Fournier, Alexa R. Green, Arthur Greenberg, Edward Lee-Ruff, Joel F. Liebman & Anita Rágyanszki. (2020) Predicted Reversal in N-Methylazepine/N-Methyl-7-azanorcaradiene Equilibrium upon Formation of Their N-Oxides. Molecules 25:20, pages 4767.
Crossref
Shumel Zbaida & Rami Kariv. (2006) Simulation of the hepatic metabolism of stilbene and its tricyclic derivatives by fenton and ruff reagents: Models for cytochrome P‐450 activation of chemical carcinogens. Biopharmaceutics & Drug Disposition 11:1, pages 39-51.
Crossref
Shmuel Zbaida & Rami Kariv. (2006) Biomimetic models for monooxygenases. Biopharmaceutics & Drug Disposition 10:5, pages 431-442.
Crossref
Sunao Kaneko, Koichi Otani, Yutaka Fukushima, Yoshihiro Ogawa, Yukimitsu Nomura, Tsuneo Ono, Yoshibumi Nakane, Takashi Teranishi & Masashi Goto. (2007) Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk Factors. Epilepsia 29:4, pages 459-467.
Crossref
GM Pacifici, M Franchi, C Bencini & A Rane. (1986) Valpromide inhibits human epoxide hydrolase.. British Journal of Clinical Pharmacology 22:3, pages 269-274.
Crossref
G.M. Pacifici, T. Tomson, L. Bertilsson & A. Rane. (1985) VALPROMIDE/CARBAMAZEPINE AND RISK OF TERATOGENICITY. The Lancet 325:8425, pages 397-398.
Crossref
Michael Höller, Karin Dengler, Karin Dietrich & Heinz Penin. (1985) Studies on the intracerebral metabolism of anticonvulsant drugs—II. Disposition of carbamazepine in the isolated perfused rat brain. Biochemical Pharmacology 34:2, pages 171-174.
Crossref
E. F. Hvidberg. 1985. Antiepileptic Drugs. Antiepileptic Drugs 725 764 .
. 1984. Comprehensive Heterocyclic Chemistry. Comprehensive Heterocyclic Chemistry 673 731 .
L.A. Damani & D.E. Case. 1984. Comprehensive Heterocyclic Chemistry. Comprehensive Heterocyclic Chemistry 223 246 .
G. M. Pacifici, C. Colizzi, L. Giuliani & A. Rane. (1983) Cytosolic epoxide hydrolase in fetal and adult human liver. Archives of Toxicology 54:4, pages 331-341.
Crossref
Hansruedi Glatt, Reinhard Jung & Franz Oesch. (1983) Bacterial mutagenicity investigation of epoxides: drugs, drug metabolites, steroids and pesticides. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 111:2, pages 99-118.
Crossref
Neville Finch. (2006) Toxicological considerations for the medicinal chemist. Medicinal Research Reviews 1:4, pages 337-372.
Crossref
M M Manson. (1980) Epoxides--is there a human health problem?. Occupational and Environmental Medicine 37:4, pages 317-336.
Crossref
M. H. Bickel. 1980. Psychotropic Agents. Psychotropic Agents 551 572 .
A. Frigerio, P. Negrini, L. Cappellini, D. Rotilio, A. De Pascale & E. Rossi. (1979) In vivo studies on the metabolism of dibenzo [c,f]-[1,2] diazepine. European Journal of Drug Metabolism and Pharmacokinetics 4:2, pages 67-74.
Crossref
A. Frigerio, P. Negrini, L. Cappellini, D. Rotilio, A. De Pascale & E. Rossi. (1979) In vitro studies on the metabolism of dibenzo[c,f]-[1,2]diazepine. European Journal of Drug Metabolism and Pharmacokinetics 4:1, pages 35-41.
Crossref
A. Frigerio, P. Negrini, D. Rotilio, A. De Pascale & E. Rossi. 1979. Recent Developments in Mass Spectrometry in Biochemistry and Medicine. Recent Developments in Mass Spectrometry in Biochemistry and Medicine 9 25 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.